These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30952894)

  • 1. Functional neutralization of anti-IFN-γ autoantibody in patients with nontuberculous mycobacteria infection.
    Krisnawati DI; Liu YC; Lee YJ; Wang YT; Chen CL; Tseng PC; Lin CF
    Sci Rep; 2019 Apr; 9(1):5682. PubMed ID: 30952894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disseminated Mycobacterium gordonae and Mycobacterium mantenii infection with elevated anti-IFN-γ neutralizing autoantibodies.
    Hase I; Morimoto K; Sakagami T; Kazumi Y; Ishii Y; van Ingen J
    J Infect Chemother; 2015 Jun; 21(6):468-72. PubMed ID: 25735882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing Activity of Anti-interferon-γ Autoantibodies in Adult-Onset Immunodeficiency Is Associated With Their Binding Domains.
    Yasamut U; Thongkum W; Moonmuang S; Sakkhachornphop S; Chaiwarith R; Praparattanapan J; Wipasa J; Chawansuntati K; Supparatpinyo K; Lai E; Tayapiwatana C
    Front Immunol; 2019; 10():1905. PubMed ID: 31474987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease.
    Aoki A; Sakagami T; Yoshizawa K; Shima K; Toyama M; Tanabe Y; Moro H; Aoki N; Watanabe S; Koya T; Hasegawa T; Morimoto K; Kurashima A; Hoshino Y; Trapnell BC; Kikuchi T
    Clin Infect Dis; 2018 Apr; 66(8):1239-1245. PubMed ID: 29126235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review.
    Hase I; Morimoto K; Sakagami T; Ishii Y; van Ingen J
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):308-315. PubMed ID: 28633901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with inhibitory and neutralizing auto-antibodies to interferon-γ resemble the sporadic adult-onset phenotype of Mendelian Susceptibility to Mycobacterial Disease (MSMD) lacking Bacille Calmette-Guerin (BCG)-induced diseases.
    Lee WI; Huang JL; Wu TS; Lee MH; Chen IJ; Yu KH; Liu CY; Yang CH; Hsieh MY; Lin YL; Shih YF; Jaing TH; Huang SC; Kuo TT; Ku CL
    Immunobiology; 2013 May; 218(5):762-71. PubMed ID: 23083630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Lymphocyte Immunophenotyping and Quantitative Anti-Interferon Gamma Autoantibodies in Taiwanese HIV-Negative Patients with Non-Tuberculous Mycobacterial Infections.
    Lee WI; Fang YF; Huang JL; You HL; Hsieh MY; Huang WT; Liang CJ; Kang CC; Wu TS
    J Clin Immunol; 2023 May; 43(4):717-727. PubMed ID: 36624329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade Effects of Anti-Interferon- (IFN-)
    Krisnawati DI; Liu YC; Lee YJ; Wang YT; Chen CL; Tseng PC; Shen TJ; Lin CF
    J Immunol Res; 2019; 2019():1629258. PubMed ID: 31275997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing QuantiFERON for Detection of Neutralizing Interferon-γ Autoantibodies in Patients With Nontuberculous Mycobacterial Infections.
    Suárez I; Lehmann C; Gruell H; Graeb J; Kochanek M; Fätkenheuer G; Plum G; van Wengen A; van de Vosse E; Hartmann P; Hanitsch LG; Rybniker J
    Clin Infect Dis; 2017 Aug; 65(3):518-521. PubMed ID: 28430999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a major epitope by anti-interferon-γ autoantibodies in patients with mycobacterial disease.
    Lin CH; Chi CY; Shih HP; Ding JY; Lo CC; Wang SY; Kuo CY; Yeh CF; Tu KH; Liu SH; Chen HK; Ho CH; Ho MW; Lee CH; Lai HC; Ku CL
    Nat Med; 2016 Sep; 22(9):994-1001. PubMed ID: 27525523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection.
    Wu UI; Chuang YC; Sheng WH; Sun HY; Jhong YT; Wang JY; Chang SC; Wang JT; Chen YC
    Clin Microbiol Infect; 2018 Feb; 24(2):159-165. PubMed ID: 28694201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of anti-cytokine antibodies may be elevated in patients with pulmonary disease associated with non-tuberculous mycobacteria.
    Kim K; Waterer G; Thomson R; Yang IA; Nashi N; Tan DB; Price P
    Cytokine; 2014 Apr; 66(2):160-3. PubMed ID: 24508556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity of Mycolicibacterium phlei, a non-pathogenic nontuberculous mycobacterium in an immunocompetent host carrying anti-interferon gamma autoantibodies: a case report.
    Tanaka S; Hoshino Y; Sakagami T; Fukano H; Matsui Y; Hiranuma O
    BMC Infect Dis; 2019 May; 19(1):454. PubMed ID: 31117976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection.
    Valour F; Perpoint T; Sénéchal A; Kong XF; Bustamante J; Ferry T; Chidiac C; Ader F;
    Emerg Infect Dis; 2016 Jun; 22(6):1124-1126. PubMed ID: 27192204
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection.
    Phoompoung P; Ankasekwinai N; Pithukpakorn M; Foongladda S; Umrod P; Suktitipat B; Mahasirimongkol S; Kiertiburanakul S; Suputtamongkol Y
    PLoS One; 2017; 12(4):e0176342. PubMed ID: 28437431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infections.
    Chi CY; Lin CH; Ho MW; Ding JY; Huang WC; Shih HP; Yeh CF; Fung CP; Sun HY; Huang CT; Wu TS; Chang CY; Liu YM; Feng JY; Wu WK; Wang LS; Tsai CH; Ho CM; Lin HS; Chen HJ; Lin PC; Liao WC; Chen WT; Lo CC; Wang SY; Kuo CY; Lee CH; Ku CL
    Medicine (Baltimore); 2016 Jun; 95(25):e3927. PubMed ID: 27336882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel assay to detect increased level of neutralizing anti-interferon gamma autoantibodies in non-tuberculous mycobacterial patients.
    Shima K; Sakagami T; Tanabe Y; Aoki N; Moro H; Koya T; Kagamu H; Hasegawa T; Suzuki E; Narita I
    J Infect Chemother; 2014 Jan; 20(1):52-6. PubMed ID: 24462426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans.
    Höflich C; Sabat R; Rosseau S; Temmesfeld B; Slevogt H; Döcke WD; Grütz G; Meisel C; Halle E; Göbel UB; Volk HD; Suttorp N
    Blood; 2004 Jan; 103(2):673-5. PubMed ID: 12947000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated nontuberculous mycobacterial infection in a patient with idiopathic CD4 lymphocytopenia and IFN-γ neutralizing antibodies: a case report.
    Goto R; Shiota S; Kaimori R; Horinouchi N; Utsunomiya Nishimizu R; Yamamoto K; Miyazaki E
    BMC Infect Dis; 2023 Jan; 23(1):58. PubMed ID: 36717786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection.
    Yoshizawa K; Aoki A; Shima K; Tanabe Y; Koya T; Hasegawa T; Kikuchi T; Sakagami T
    J Clin Immunol; 2020 Feb; 40(2):399-405. PubMed ID: 32034574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.